RhumbLine Advisers’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
151,372
+10,168
| +7% | +$173K | ﹤0.01% | 1752 |
|
|
2025
Q1 | $2.76M | Buy |
141,204
+14,971
| +12% | +$292K | ﹤0.01% | 1651 |
|
|
2024
Q4 | $3.13M | Sell |
126,233
-872
| -0.7% | -$21.6K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $3.11M | Sell |
127,105
-5,464
| -4% | -$134K | ﹤0.01% | 1665 |
|
|
2024
Q2 | $3.11M | Buy |
132,569
+23,565
| +22% | +$552K | ﹤0.01% | 1657 |
|
|
2024
Q1 | $3.6M | Buy |
109,004
+4,792
| +5% | +$158K | ﹤0.01% | 1596 |
|
|
2023
Q4 | $2.84M | Sell |
104,212
-1,284
| -1% | -$35K | ﹤0.01% | 1727 |
|
|
2023
Q3 | $2.54M | Buy |
105,496
+10,412
| +11% | +$250K | ﹤0.01% | 1746 |
|
|
2023
Q2 | $3.04M | Buy |
95,084
+7,136
| +8% | +$228K | ﹤0.01% | 1677 |
|
|
2023
Q1 | $2.69M | Buy |
87,948
+1,408
| +2% | +$43.1K | ﹤0.01% | 1655 |
|
|
2022
Q4 | $3.39M | Buy |
86,540
+1,583
| +2% | +$61.9K | ﹤0.01% | 1516 |
|
|
2022
Q3 | $4.05M | Buy |
84,957
+8,763
| +12% | +$417K | 0.01% | 1355 |
|
|
2022
Q2 | $2.95M | Buy |
76,194
+21,992
| +41% | +$851K | ﹤0.01% | 1551 |
|
|
2022
Q1 | $3.11M | Buy |
54,202
+2,389
| +5% | +$137K | ﹤0.01% | 1584 |
|
|
2021
Q4 | $4.13M | Sell |
51,813
-128
| -0.2% | -$10.2K | 0.01% | 1468 |
|
|
2021
Q3 | $4.52M | Buy |
51,941
+3,210
| +7% | +$279K | 0.01% | 1415 |
|
|
2021
Q2 | $6.27M | Buy |
48,731
+5,030
| +12% | +$647K | 0.01% | 1299 |
|
|
2021
Q1 | $3.5M | Sell |
43,701
-2,536
| -5% | -$203K | ﹤0.01% | 1608 |
|
|
2020
Q4 | $3.78M | Buy |
46,237
+9,204
| +25% | +$751K | 0.01% | 1518 |
|
|
2020
Q3 | $912K | Buy |
37,033
+22,386
| +153% | +$551K | ﹤0.01% | 2031 |
|
|
2020
Q2 | $410K | Buy |
14,647
+2,954
| +25% | +$82.7K | ﹤0.01% | 2434 |
|
|
2020
Q1 | $210K | Buy |
+11,693
| New | +$210K | ﹤0.01% | 2562 |
|